Welcome to the Seloken® ZOK website which is intended for an international audience of healthcare professionals. Before prescribing Seloken ZOK, please consult your local prescribing information.

U.S. residents, please visit www.Toprol-XL.com

News
- Jul 24, 2008 : Emergency physicians correctly diagnosing EMI
- Jul 24, 2008 : Parietal lobe stroke linked to poor cardiac outcomes
- Jul 23, 2008 : HF epidemic claims contradicted
- Jul 23, 2008 : OSA reverses diurnal MI incidence
more news
HIGHLIGHTS
- Seloken Summary Once-daily Seloken® ZOK (metoprolol CR/XL) is the world's leading beta-blocker and the only beta-blocker indicated for the treatment of hypertension, angina pectoris, and heart failure.
- Heart Failure 2005 Read a selection of reports from the Heart Failure Update 2005 held in Lisbon 11 - 14 June 05
- ACC 2005 Read a selection of reports from the American College of Cardiology held 5-9 March 2005 Orlando, Florida

We refer you to our Legal Statement, Privacy Policy and Terms and Conditions which contain important information relating to the use of this website.

Astrazeneca Worldwide